- October 10, 2014Kyorin Pharmaceutical and R-Pharm Reach Agreement in Russia and neighboring nations for Activities Related to the Development and Marketing of Imidafenacin
- September 10, 2014EISAI AND KYORIN ENTER INTO AGREEMENT CONCERNING COMPOUND LIBRARY USE FOR THE DEVELOPMENT OF NEW ANTIBACTERIAL AGENTS
- July 22, 2014Kyorin signed a License Agreement with Merck on Vibegron for Overactive Bladder in Japan
- July 1, 2014Gene-Therapy Product for the Treatment of Malignant Pleural Mesothelioma adopted as Next generation Technology Transfer Program (NexTEP) by JST
- November 19, 2013Release of Flutiform, a combination drug for asthma treatment
- October 17, 2013Kyorin and Kissei announce the initiation of a Phase I clinical trial of KRP-EPA605/ KEA-0447 for the treatment of overactive bladder
- September 20, 2013Approval received for Flutiform, a combination drug for asthma treatment
- March 25, 2013Approval Received for PENTASA® Suppositories 1g,a Drug for Ulcerative colitis.